Interference microscopy

Semarion Introduces SemaCyte Multiplexing Platform to Enhance Cell Assay Data Quality and Speed During Drug Discovery

Retrieved on: 
Wednesday, March 20, 2024
Research, Medical Devices, Health Technology, Stem Cells, Biotechnology, Health, Pharmaceutical, Science, Oncology, AZD5363, Cell, Platform, Entrepreneurship, Drug discovery, Material, Partnership, Cell biology, Interference microscopy, Nanomagnet, University, University of Cambridge, HCI, CRISPR, Cavendish Laboratory, Engineering, Mobile phone

Designed specifically to augment microplate-based high-content imaging (HCI) approaches, the platform enables in situ multiplexing of adherent cells using the Company’s proprietary microcarriers, SemaCytes, to enhance both the quality and speed of data generation.

Key Points: 
  • Designed specifically to augment microplate-based high-content imaging (HCI) approaches, the platform enables in situ multiplexing of adherent cells using the Company’s proprietary microcarriers, SemaCytes, to enhance both the quality and speed of data generation.
  • The SemaCyte Multiplexing Platform uses optical barcodes to tag and differentiate individual cells and cell types while preserving natural morphology, with each microcarrier capable of carrying millions of unique identifiers.
  • The Multiplexing Platform can be used across a broad range of applications, including target identification, compound screening and compound profiling.
  • The Multiplexing Platform has been developed to further leverage Semarion’s innovative microcarrier technology, SemaCytes, in advancing drug discovery workflows.

Transmission Electron Microscope Market Projected to Reach $3.92 billion by 2030 - Exclusive Report by 360iResearch

Retrieved on: 
Thursday, March 28, 2024
Dark, Growth, Transmission electron cryomicroscopy, Thermo Fisher Scientific, Critical Role, Science, Intelligence, Nanoparticle, Research, Electron, Electronics, Nanotechnology, TEM, AI, Dislocation, Bruker, Biology, NanoWorld, Hitachi, Transmission electron microscopy, Architecture, Investment, Semiconductor, Miniaturization, Aberration, Interference microscopy, Table, Carl Zeiss AG, Microscope

Transmission electron microscopy (TEM) is a pivotal analytical tool across various scientific disciplines, including nanotechnology, materials science, and biology.

Key Points: 
  • Transmission electron microscopy (TEM) is a pivotal analytical tool across various scientific disciplines, including nanotechnology, materials science, and biology.
  • The key players in the Transmission Electron Microscope Market include Thermo Fisher Scientific Inc., Carl Zeiss AG, AMETEK, Inc, Bruker Corporation, Hitachi Ltd., and others.
  • We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Transmission Electron Microscope Market.
  • "Dive into the Transmission Electron Microscope Market Landscape: Explore 183 Pages of Insights, 574 Tables, and 26 Figures"

Transmission Electron Microscope Market Projected to Reach $3.92 billion by 2030 - Exclusive Report by 360iResearch

Retrieved on: 
Thursday, March 28, 2024
Dark, Growth, Transmission electron cryomicroscopy, Thermo Fisher Scientific, Critical Role, Science, Intelligence, Nanoparticle, Research, Electron, Electronics, Nanotechnology, TEM, AI, Dislocation, Bruker, Biology, NanoWorld, Hitachi, Transmission electron microscopy, Architecture, Investment, Semiconductor, Miniaturization, Aberration, Interference microscopy, Table, Carl Zeiss AG, Microscope

Transmission electron microscopy (TEM) is a pivotal analytical tool across various scientific disciplines, including nanotechnology, materials science, and biology.

Key Points: 
  • Transmission electron microscopy (TEM) is a pivotal analytical tool across various scientific disciplines, including nanotechnology, materials science, and biology.
  • The key players in the Transmission Electron Microscope Market include Thermo Fisher Scientific Inc., Carl Zeiss AG, AMETEK, Inc, Bruker Corporation, Hitachi Ltd., and others.
  • We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Transmission Electron Microscope Market.
  • "Dive into the Transmission Electron Microscope Market Landscape: Explore 183 Pages of Insights, 574 Tables, and 26 Figures"

Edinburgh Fringe 2023: how to immerse yourself in the world's biggest arts festival

Retrieved on: 
Friday, August 4, 2023
Heart, Technology, Darkness, Joke, Edinburgh Festival Fringe, Edinburgh International Festival, Noise, The League of Gentlemen, League, Interference microscopy, Edinburgh Comedy Awards, Fleabag, Name, Potterrow Student Centre, Summerhall, Time, Burlesque, Film industry, Nightclub, Entertainment, Interior design, Sin, Fringe, Eulogy

When the Edinburgh International Festival launched in 1947, it was inevitable that a fringe event would follow.

Key Points: 
  • When the Edinburgh International Festival launched in 1947, it was inevitable that a fringe event would follow.
  • Beginning with just eight companies of performers in five venues, the Edinburgh Festival Fringe (known as “the Fringe”) is now the biggest arts festival in the world, and welcomes tens of thousands of performers across over 250 venues every August.

First things first

    • The tradition of discovering emerging stars, especially those who have won an award, is often characterised by winning a Fringe First.
    • The scale of the Fringe, however, means that it’s difficult to know who or what might be the next big thing.

Before you go: do your homework

    • Looking at the programme online to plan your visit is almost as daunting as attending the Fringe itself.
    • Everywhere you turn you’re confronted with impromptu acts of performance, colourful characters and flyers decorating the city’s old streets advertising myriad shows.
    • Spending some time in advance choosing what to watch can help curate a more fulfilling experience.

Dive right in

    • Everywhere the city is alive with sights, sounds, smells, tastes and tactile experiences to be enjoyed.
    • Without Sin (at Summerhall) is described as a “contemporary confessional for the modern sinner” for an audience of two.
    • The producing company, Darkfield, is known for using technology to create immersive experiences, both in-person and through an app.

Something for everyone

    • As a spectator, having a “successful” Fringe experience doesn’t necessarily mean catching the big zeitgeist comedian or bagging tickets for the latest show from a star actor.
    • A successful visit to the Fringe might just mean you’ve soaked up the atmosphere, seen some interesting shows and come away feeling stimulated by the experience.
    • Seeing something truly terrible is all part of the Fringe experience and can help us hone our instincts for the good stuff in future.

Nikon introduces the AX R MP with NSPARC Super-resolution Multiphoton Confocal Microscope

Retrieved on: 
Thursday, July 27, 2023
CFI, Central nervous system, Nikon, Lens, Data collection, Research, Interference microscopy, Alzheimer's disease, Dementia, Parkinson's disease, Myenteric plexus, Madras motor neuron disease, Wide-field multiphoton microscopy, Nervous system, Drug discovery, NIS, AI, AX, Glass, NIR, Microscope, Medical imaging, Medical device

MELVILLE, N.Y., July 27, 2023 /PRNewswire/ -- Nikon Instruments Inc. has announced the release of the AX R MP with NSPARC super-resolution multiphoton confocal microscope, which enables extremely sensitive array detection and super-resolution in deep areas within large living organism specimens. This product will contribute to the understanding of brain diseases such as Alzheimer's and Parkinson's disease, as well as drug discovery research.

Key Points: 
  • MELVILLE, N.Y., July 27, 2023 /PRNewswire/ -- Nikon Instruments Inc. has announced the release of the AX R MP with NSPARC super-resolution multiphoton confocal microscope , which enables extremely sensitive array detection and super-resolution in deep areas within large living organism specimens.
  • In addition, Nikon released the AX R MP multiphoton confocal microscope last year, providing high-resolution, high-speed, large field-of view images in deep areas within living bodies.
  • Further demonstrating Nikon's commitment to continued development of current product offerings, the NIR Imaging Option , for use in combination with the AX and AX R confocal microscopes, will also be released simultaneously with the AX R MP with NSPARC.
  • With the AX / AX R confocal microscope and AX R MP with NSPARC, Nikon continues to make products available to support research on life phenomena, and expand its range of products, providing the flexibility to meet customers' research needs.

Two Renowned Cancer Experts to Head New Tisch Cancer Hospital at The Mount Sinai Hospital

Retrieved on: 
Thursday, March 16, 2023
National Cancer Institute (Egypt), Research, Cancer, Health, Nephrology, Nursing, MD, Hospital, Trustee, Bangladesh Technical Education Board, Department of Defense Serum Repository, Medicine, Mount Sinai Hospital (Manhattan), School, Mount Sinai Health System, Principal investigator, Surgeon, Prostate cancer, Informatics, Icahn School of Medicine at Mount Sinai, Social justice, Patient, Sinai Health System, Interference microscopy, Madison Avenue, National Cancer Institute, Medical director, American Cancer Society, Master of Surgery, Faculty, MBBS, Surgical oncology, Cardiology, Knowledge, Health system, Doctor of Philosophy, Geriatrics, Lead, News, Artificial intelligence, Dentistry, Tisch, Urology

NEW YORK, March 16, 2023 /PRNewswire-PRWeb/ -- Two top cancer experts have been named to lead Mount Sinai's new Tisch Cancer Hospital, which is under development and due to open in 2027. Cardinale B. Smith, MD, PhD, has been appointed Chief Medical Officer for the Tisch Cancer Hospital and Vice President of Cancer Clinical Affairs, and Ash Tewari, MBBS, MCh, has been appointed Surgeon-in-Chief of the Tisch Cancer Hospital.

Key Points: 
  • Cardinale B. Smith, MD, PhD, has been appointed Chief Medical Officer for the Tisch Cancer Hospital and Vice President of Cancer Clinical Affairs, and Ash Tewari, MBBS, MCh, has been appointed Surgeon-in-Chief of the Tisch Cancer Hospital.
  • The Tisch Cancer Hospital will be a state-of-the-art cancer facility at The Mount Sinai Hospital, thanks to a generous $60 million gift from James S. and Merryl H. Tisch.
  • "Mount Sinai's vision for the Tisch Cancer Hospital was bold," said Mr. Tisch, Co-Chairman of the Boards of Trustees of the Mount Sinai Health System.
  • "The Tisch Cancer Hospital will be a hospital within the hospital that is supported by experts from various areas of medicine," Dr. Tewari said.